ImmunityBio (IBRX) Amortizatization of Intangibles (2015 - 2026)
ImmunityBio's (IBRX) quarterly Amortizatization of Intangibles came in at $1.5 million in Q1 2026, up 2834.62% year-on-year from $52000.0 in Q1 2025, and down 10.45% on a QoQ basis from $1.7 million in Q4 2025.
ImmunityBio (IBRX) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 12 years of Amortizatization of Intangibles data on file, last reported at $1.5 million in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 2834.62% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $4.2 million, a 301.81% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 84.35% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $1.5 million, down from $1.7 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for IBRX reached as high as $1.7 million in Q4 2025 and fell as low as -$10000.0 in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $490583.3 across 5 years, with a median of $257500.0 in 2023.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 7000.0% in 2025 and fell as far as 97.21% in 2025.
- Year by year, Amortizatization of Intangibles stood at -$10000.0 in 2022, then jumped by 1310.0% to $121000.0 in 2023, then plunged by 80.17% to $24000.0 in 2024, then jumped by 7000.0% to $1.7 million in 2025, then retreated by 10.45% to $1.5 million in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.5 million in Q1 2026, $1.7 million in Q4 2025, and $978000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | ImmunityBio | 7.22 Bn | 6.84 Bn | 43.97 Mn | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | 978,000.00 |
| Sep 30, 2025 | 978,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Sep 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 394,000.00 |
| Jun 30, 2024 | 394,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Mar 31, 2024 | 491,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Dec 31, 2023 | 121,000.00 |